DOT-C: A cluster randomised feasibility trial evaluating directly observed anti-HCV therapy in a population receiving opioid substitute therapy from community pharmacy

Andrew Radley (Lead / Corresponding author), Jan Tait, John F. Dillon

    Research output: Contribution to journal › Article › peer-review

    55 Citations (Scopus)
    402 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'DOT-C: A cluster randomised feasibility trial evaluating directly observed anti-HCV therapy in a population receiving opioid substitute therapy from community pharmacy'. Together they form a unique fingerprint.

    Keyphrases

    Pharmacology, Toxicology and Pharmaceutical Science